× Didn't find what you were looking for? Ask a question
Top Posters
Since Sunday
a
5
k
5
c
5
B
5
l
5
4
C
4
s
4
a
4
t
4
i
4
r
4
New Topic  
stoneskin21 stoneskin21
wrote...
Posts: 301
Rep: 0 0
5 years ago
Manufacturers start developing their trade names for a new drug during which of the following drug approval phases?
A) Clinical phase 1 trials
B) Clinical phase 2 trials
C) Clinical phase 3 trials
D) Phase IV
Textbook 
Focus on Pharmacology: Essentials for Health Professionals

Focus on Pharmacology: Essentials for Health Professionals


Edition: 3rd
Author:
Read 41 times
1 Reply

Related Topics

Replies
wrote...
5 years ago
 A
Explanation:  A) In Clinical Phase 1 trials, manufacturers start developing their trade name for a new drug. Dosages and adverse effects are assessed on approximately 20-100 human volunteers initially, who have the disease or condition that the drug is being tested to treat. Doses are often subtherapeutic, but ascending (increasing) doses are used.
 
New Topic      
Explore
Post your homework questions and get free online help from our incredible volunteers
  1280 People Browsing
Related Images
  
 1584
  
 575
  
 651
Your Opinion
Which industry do you think artificial intelligence (AI) will impact the most?
Votes: 352

Previous poll results: Do you believe in global warming?